Mentetra^®

Description

Quadrivalent conjugate polysaccharide meningococcal vaccine.

Indication

Prevention of meningococcal infection in children aged 3 months to 55 years. The vaccine provides protection against the four main meningococcal serogroups (A, C, W, and Y).

Product form

Solution for injection.